Zurich Cantonal Bank
CCCC icon

Zurich Cantonal Bank’s C4 Therapeutics CCCC Stock Holding History

Zurich Cantonal Bank’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-6,001
Closed -$18.8K – 2809
2023
Q1 		$18.8K Buy
6,001
+2,580
+75% +$15.2K ﹤0.01% 2762
2022
Q4 		$20.2K Hold
3,421
– – ﹤0.01% 2754
2022
Q3 		$30K Hold
3,421
– – ﹤0.01% 2728
2022
Q2 		$26K Hold
3,421
– – ﹤0.01% 2751
2022
Q1 		$83K Hold
3,421
– – ﹤0.01% 2356
2021
Q4 		$110K Buy
+3,421
New +$135K ﹤0.01% 2459

Other funds holding CCCC

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Zurich Cantonal Bank's CCCC Position: Q2 2023 in Review

Zurich Cantonal Bank sold out of C4 Therapeutics (CCCC) in Q2 2023, closing a stake of 6,001 shares — an estimated $18.8K sold.

Zurich Cantonal Bank first reported a position in CCCC in Q4 2021 and held it in 6 quarters. The position peaked at $110K in Q4 2021. 100 funds tracked by Wall St. Rank hold CCCC as of Q2 2023.

  • Zurich Cantonal Bank reported no remaining C4 Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Zurich Cantonal Bank sold 6,001 C4 Therapeutics shares in Q2 2023, an estimated $18.8K.
  • Zurich Cantonal Bank first reported a position in C4 Therapeutics in Q4 2021 and held it in 6 quarters.
  • Zurich Cantonal Bank's C4 Therapeutics position peaked at $110K in Q4 2021.
  • 100 funds tracked by Wall St. Rank held C4 Therapeutics as of Q2 2023.

Based on Zurich Cantonal Bank's 13F filing for Q2 2023, filed 7 Aug 2023.